Calithera Biosciences

September 05, 2019

Esmo 2019 preview – Parps on parade

Among small-molecule approaches Europe’s premier oncology conference gives star billing to three Parp inhibitors in ovarian cancer.

October 11, 2017

World Lung and SITC – two more doses of oncology

January 31, 2017

Incyte gives Calithera a new lease of life

June 10, 2016

Asco event analyser – 2016’s winners and losers

July 03, 2015

Sector’s smaller players show the way

June 03, 2015

Asco Event Analyzer – 2015’s winners and losers

April 08, 2015

Therapy focus – Potential for progress in mesothelioma is on the horizon

January 05, 2015

Strong quarter sees 2014 race to record IPO haul

August 28, 2014

From summer lull to biotech’s record-breaking month